In order to better match the chemokine secreted by tumor cells, some studies have introduced chemokine receptors such as CCR2b into CAR-T cells through genetic modification and promoted the transport by the large amount of CCL2 secreted by tumor cells (30). The gene discussed is CCR2; the disease is neoplasm.